Features of portal hemodynamics in patients with fatty liver disease: mechanisms of formation, clinical significance

There are few data in the literature on the state of portal and hepatic blood flow in patients with fatty liver disease, and portal hemodynamics at the pre-cirrhotic stage is practically not covered. The aim of the study was to study the features of portal hemodynamics in patients with fatty liver disease at the pre-cirrhotic stage. Materials and methods. The study included 43 patients (25 - patients with fatty liver disease and 18- a comparison group who applied to outpatient clinics of therapeutic profile aged 18-89 years (41.9% of men, 58.1% of women). The average age of the patients was 45.1± 19.4 years. Criteria for inclusion in the study: age 18 years and older; presence of fatty liver disease associated with metabolic conditions. Criteria for not being included in the study: the presence of viral hepatitis, alcoholic liver disease, autoimmune liver diseases, pregnancy, lactation, taking any medications, narcotic drugs, the presence of acute or exacerbation of chronic diseases. The anthropometric indicators of patients were evaluated: waist circumference (OT), body mass index (BMI), steatotic indices (St-index, Fatty Liver Index), liver fibrosis index (Fib 4). Portal hemodynamics was assessed using ultrasound Dopplerography on a Philips Affiniti 50 device. Sensor C5-1. The following criteria were evaluated: vessel diameter (mm), its cross-sectional area (PPP, cm2), time-averaged maximum velocity (TAMX, cm/s), time-averaged average blood flow velocity (TAV, cm/s), Doppler perfusion index was calculated using the formula: V vol SPA / V vol SPA + V vol BB), the stagnation index was calculated using the formula: PPP/TAV. The results obtained. In patients with fatty liver disease, structural and hemodynamic shifts in the portal blood flow system are recorded: an increase in the diameter of the portal and inferior vena cava, a larger cross-sectional area, a low time-averaged maximum blood flow velocity and time-averaged average blood flow velocity, an increase in the stagnation index for these vessels, which reflects the process of remodeling the liver as a target organ in fatty liver disease and its vascular bed, forming a “stagnant liver”. Patients have lower values of the time-averaged average blood flow rate through the splenic vein, which indicates the initiation of collateral blood flow. Portal hemodynamics indicators correlate with metabolic parameters (anthropometric characteristics of patients (OT, BMI), steatotic indices (St index, FLI), but not with the liver fibrosis index (Fib 4). These hemodynamic features at the pre-cirrhotic stage of the disease, correlating with the severity of metabolic disorders, exacerbate structural changes in the liver and necessitate their correction in patients with fatty liver disease.

fatty liver disease, hemodynamics, blood flow through the portal, inferior vena cava, splenic vein, stagnation index

1. Mayev I.V., Andreev D. N., Kucheryavy Yu. A. Prevalence of non-alcoholic fatty liver disease in Russia: meta-analysis. Consilium Medicum. 2023;25(5):313-319. (in Russ.) doi: 10.26442/20751753.2023.5.202155.@@ Маев И. В., Андреев Д. Н., Кучерявый Ю. А. Распространенность неалкогольной жировой болезни печени в России: метаанализ. Consilium Medicum. 2023;25(5):313-319. doi: 10.26442/20751753.2023.5.202155.

2. Younossi Z. M., Golabi P., Paik J. M. et al. The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review. Hepatology. 2023;77(4):1335-47. doi: 10.1097/HEP.0000000000000004.

3. Eslam M., Newsome P. N., Sarin S. K. et al. A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol. 2020;73:202-9. doi: 10.1016/j.jhep.2020.03.039.

4. Lazebnik L. B., Golovanova E. V., Turkina S. V. et al. Non-alcoholic fatty liver disease in adults: clinic, diagnosis, treatment. Recommendations for therapists, the third version. Experimental and clinical gastroenterology. 2021;185(1): 4-52. (in Russ.) doi: 10.31146/1682-8658-ecg-185-1-4-52.@@ Лазебник Л. Б., Голованова Е. В., Туркина С. В. и Соавт. Неалкогольная жировая болезнь печени у взрослых: клиника, диагностика, лечение. Рекомендации для терапевтов, третья версия. Экспериментальная и клиническая гастроэнтерология. 2021;185(1): 4-52. doi: 10.31146/1682-8658-ecg-185-1-4-52.

5. Ivashkin V.T., Maevskaya M. V., Zharkova M. S. et al. Clinical Practice Guidelines of the Russian Scientific Liver Society, Russian Gastroenterological Association, Russian Association of Endocrinologists, Russian Association of Gerontologists and Geriatriciansand National Society for Preventive Cardiology on Diagnosis and Treatment of Non-AlcoholicLiver Disease.Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2022;32(4):104-40. (in Russ.) doi: 10.22416/1382-4376-2022-32-4-104-140.@@ Ивашкин В. Т., Маевская М. В., Жаркова М. С. и др. Клинические рекомендации Российского общества по изучению печени, Российской гастроэнтерологической ассоциации, Российской ассоциации эндокринологов, Российской ассоциации геронтологов и гериатров и Национального общества профилактической кардиологии по диагностике и лечению неалкогольной жировой болезни печени. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2022;32(4):104-40. doi: 10.22416/1382-4376-2022-32-4-104-140.

6. Gudinova J.V. [Friendly statistics: statistical analysis of medical databases: step-by-step instructions]. / (Edd.)J. V. Gudinova, G. N. Zhernakova, E. I. Tolkova. Omsk. Omsk State Medical University Publ., 2014. 112 p. (in Russ.)@@ Гудинова, Ж. В. Дружелюбная статистика: статистический анализ медицинских баз данных: пошаговые инструкции / Ж. В. Гудинова, Г. Н. Жернакова, Е. И. Толькова. - Омск: Омский государственный медицинский университет, 2014. - 112 с.

7. Ekstedt M., Hagstrom H., Nasr P. et al. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up. Hepatology. 2015;61:1547-1554. doi: 10.1002/hep.27368.

8. Ratziu V., Charlotte F., Heurtier A. et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology. 2005;128:1898-1906. doi: 10.1053/j.gastro.2005.03.084.

9. Ginès P., Graupera I., Lammert F. et al. Screening for liver fibrosis in the general population: a call for action. Lancet Gastroenterol Hepatol. 2016;1:256-60. doi: 10.1016/S2468-1253(16)30081-4.

10. DeLucia Rolfe E., Brage S., Sleigh A., Finucane F., Griffin S. J., Wareham N. J., Ong K. K., Forouhi N. G. Validity of ultrasonography to assess hepatic steatosis compared to magnetic resonance spectroscopy as a criterion method in older adults. PLoS One. 2018 Nov 26;13(11): e0207923. doi: 10.1371/journal.pone.0207923.

11. Kuntsevich G. I. [Color Doppler mapping and pulse Dopplerography of abdominal vessels]. / (Edd.) G. I. Kuntsevich, E. A. Belolapotko. In Book: Ultrasound Doppler diagnostics of vascular diseases. Moscow. Vidar, 1998: 297-Z10. (in Russ.)@@ Кунцевич Г. И. Цветовое допплеровское картирование и импульсная доплерография абдоминальных сосудов / Г. И. Кунцевич, Е. А. Белолапотко // Ультразвуковая доплеровская диагностика сосудистых заболеваний. - Москва: Видар, 1998. - С. 297-З10.

12. Lelyuk V.G., Lelyuk S. E. [Fundamentals of clinical interpretation of ultrasound angiological research data]. Moscow, 2005. 38 p. (in Russ.)@@ Лелюк В. Г. Основы клинической интерпретации данных ультразвуковых ангиологических исследований: учеб.-метод. пособие / В. Г. Лелюк, С. Э. Лелюк. - Москва, 2005. - 38 с.

13. Lelyuk V. G., Lelyuk S. E. [Ultrasound assessment of the peripheral venous system in normal and in various pathological processes]. Moscow, 2004. 40 p. (in Russ.)@@ Лелюк В. Г. Ультразвуковая оценка периферической венозной системы в норме и при различных патологических процессах: учеб.-метод. пособие / В. Г. Лелюк, С. Э. Лелюк. - Москва, 2004. - 40 с.

14. Zironi G., Gaiani S., Fenyves D., Rigamonti A., Bolondi L., Barbara L. Value of measurement of mean portal flow velocity by Doppler flowmetry in the diagnosis of portal hypertension. J Hepatol. 1992 Nov;16(3):298-303. doi: 10.1016/s0168-8278(05)80660-9.

15. Brown H.S., Halliwell M., Qamar M., Read A. E., Evans J. M., Wells P. N. Measurement of normal portal venous blood flow by Doppler ultrasound. Gut. 1989 Apr;30(4):503-9. doi: 10.1136/gut.30.4.503.

16. Iwao T., Toyonaga A., Oho K., Tayama C., Masumoto H., Sakai T., Sato M., Tanikawa K. Value of Doppler ultrasound parameters of portal vein and hepatic artery in the diagnosis of cirrhosis and portal hypertension. Am J Gastroenterol. 1997 Jun;92(6):1012-7. PMID: 9177521.

17. Walsh K.M., Leen E., MacSween R.N., Morris A. J. Hepatic blood flow changes in chronic hepatitis C measured by duplex Doppler color sonography: relationship to histological features. Dig Dis Sci. 1998 Dec;43(12):2584-90. doi: 10.1023/a:1026626505517.

18. Zwibel V. [Ultrasound examination of blood vessels: trans. from English]. / (Edd.) V. Zwibel, J. Pellerito. 5th ed. Moscow. VIDAR Publ., 2008. 608 p. (in Russ.) ISBN: 978-5-88429-119-5.@@ Цвибель В. Ультразвуковое исследование сосудов: пер. с англ. / В. Цвибель, Дж. Пеллерито. - 5-е изд. - Москва: ВИДАР, 2008. - 608 с. ISBN 978-5-88429-119-5.

19. Mitkova V.V. [Practical guide to ultrasound diagnostics. General ultrasound diagnostics]. reprint. Vidar-M Publ., 2019, 756 p. (in Russ.)@@ Практическое руководство по ультразвуковой диагностике. Общая ультразвуковая диагностика. Под ред. Митькова В. В. 3-е изд., перераб. и доп. Видар-М, 2019, 756 с.

20. Kamalov Y. R., Kryzhanovskaya E. Y., Lyubivy E. D. Hepatic blood flow in cirrhosis of the liver depending on the stage of Child-Turcotte-Pugh and the degree of varicose veins of the esophagus. Ultrasound and functional diagnostics. 2013;(2):55-63. (in Russ.) EDN: QIODOJ.@@ Камалов Ю. Р., Крыжановская Е. Ю., Любивый Е. Д. Печеночный кровоток при циррозе печени в зависимости от стадии по Child-Turcotte-Pugh и степени варикозного расширения вен пищевода. Ультразвуковая и функциональная диагностика. - 2013. - № 2. - С. 55-63. - EDN: QIODOJ.

21. Zoli M., Marchesini G., Cordiani M. R., Pisi P., Brunori A., Trono A., Pisi E. Echo-Doppler measurement of splanchnic blood flow in control and cirrhotic subjects. J Clin Ultrasound. 1986 Jul-Aug;14(6):429-35. doi: 10.1002/ jcu.1870140605.

22. Jesus S.M., Siddiqui S. I., Silva A. Path specific Doppler compensation in time-reversal communications. J Acoust Soc Am. 2015 Apr;137(4): EL300-6. doi: 10.1121/1.4915005.

23. Kakkos S.K., Yarmenitis S. D., Tsamandas A. C., Gogos C. A., Kalfarentzos F. Fatty liver in obesity: relation to Doppler perfusion index measurement of the liver. Scand J Gastroenterol. 2000 Sep;35(9):976-80. doi: 10.1080/003655200750023066.

24. Riahinezhad M., Saneian H., Farghadani M., Parsai Arshad S. Doppler perfusion index in adolescents with non-alcoholic fatty liver disease. Immunopathol Persa. 2021;7(1): e07. doi: 10.34172/ ipp.2021.07.

25. Raevneva T. G. Violations of intrahepatic hemodynamics in acute and chronic hepatitis, detected by ultrasound Dopplerometry. Radiation Diagnostics News. 2000;(2): 29-31. (in Russ.)@@ Раевнева Т. Г. Нарушения внутрипеченочной гемодинамики при острых и хронических гепатитах, выявляемые с помощью ультразвуковой допплерометрии. Новости лучевой диагностики. 2000;(2): 29-31.

26. Seifalian A.M., Chidambaram V., Rolles K., Davidson B. R. In vivo demonstration of impaired microcirculation in steatotic human liver grafts. Liver Transpl Surg. 1998 Jan;4(1):71-7. doi: 10.1002/lt.500040110.

27. Farrell G.C., Teoh N. C., McCuskey R. S. Hepatic microcirculation in fatty liver disease. Anat Rec (Hoboken). 2008 Jun;291(6):684-92. doi: 10.1002/ar.20715.